fbpx
Skip links
Board Certified in Family Medicine

Dr. Humberto Fernandez-Miro

Dr. Humberto Fernandez Miro is a highly esteemed board-certified physician with over 25 years of extensive experience in Miami's medical landscape. With a steadfast commitment to preventive healthcare, he employs a holistic approach to patient care that prioritizes clear communication and bilingual services to meet the diverse needs of his patients.

Currently, Dr. Fernandez Miro serves as the Medical Director and Principal Investigator at Global Health Clinical Trials and the Renova Aesthetics Institute, where he is at the forefront of innovative research and clinical trials. His work significantly advances medical knowledge, particularly in the realm of regenerative medicine, where he is a key figure in pioneering stem cell treatments at Miami Stem Cell.

Aesthetics and Plastic Surgical Procedures Experience

Dr. Fernandez Miro specializes in a comprehensive array of procedures, including non-surgical treatments such as Botox and dermal fillers, advanced skin rejuvenation techniques, and various laser treatments. He also specializes in plastic surgical procedures, including facelifts, breast augmentation, and body contouring. Additionally, he manages the Erectile Dysfunction program at Renova, providing comprehensive assessments and tailored treatments to help patients regain confidence and improve their quality of life. Dr. Fernandez Miro also offers Testosterone Replacement Therapy, addressing hormonal imbalances to enhance overall health and well-being. His approach to the Weight Control Management Program integrates lifestyle modifications and medical support to help patients achieve their health and aesthetic goals.

A prolific contributor to national and international clinical trials, Dr. Fernandez Miro has conducted research on a wide range of medical conditions, including COPD, asthma, acne, dermatitis, pain management, infectious diseases, diabetes, obesity, cardiovascular diseases, and neurological disorders. During the COVID-19 pandemic, he partnered with Pfizer, Gilead, Shionogi, and other pharmaceutical companies to test various drugs for treatment in both adult and pediatric populations, as well as prevention strategies. His pioneering work in this area has contributed valuable insights into the understanding and management of COVID-19.

Dr. Fernandez Miro is actively involved in collaborative research initiatives, often partnering with leading institutions to explore innovative therapies and techniques. His dedication to education extends beyond research; he frequently speaks at national and international conferences, sharing insights and fostering dialogue on the evolving landscape of medicine. His passion for education and innovation drives his commitment to delivering exceptional patient care and advancing the standards of medical practice.

Research experience

Observational Registry of Treatment Patterns in U.S Heart Failure Patients with Reduce Ejection Fraction

Effect of Metformin HCL in Combination with Colesevelam HCL, Compared to Metformin HCL Alone as Initial Therapy in Drug Naïve Subjects with Type 2 Diabetes Mellitus

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) with Psoriasis Vulgaris.

Comprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Community (COPD_CDM).

Effect of Colesevelam HCL on the lipid profile in Subject with Pre-Diabetes.

Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas

A study of Valsartan Administered once daily versus twice daily in patients with stable CHF.

Migraine Prevention using ActiPatch (PSWT)

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of SNA-120 Ointment in Subjects With Pruritus Associated With Psoriasis Vulgaris.

COPD Patients Diagnosed With GERD, COPD Exacerbations After Treatment with High Dose PPI

Airway Inflammation, Symptoms and Lung Function in COPD.

The effect of certolizumab on MRI Synovitis in Rheumatoid Arthritis.

A Phase III Protocol to evaluate Pharmacokinetic Comparison of Three NPH Insulin Preparations.

Impact Rituximab on MRI Evidence of Disease Activity in Patients with Rheumatoid Arthritis.

Comparative Randomized Bioavailability Study of a Combination Antihistamine and Decongestant Caplet given as a Single Dose.

A Randomized Multicenter, Double Blind, parallel Placebo Controlled Study of the effects of JNJ-28431754 on Cardiovascular Outcomes in Adults Subjects with type 2 Diabetes Mellitus (Johnson & Johnson Pharmaceutical research & development)

A multicenter, international, randomized parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 Diabetes Mellitus at high cardiovascular risk. (Boehringer)

Cassiopeia, Facial Acne Study CB-03-01/25 A phase 3, Multicenter, randomized, double blind, vehicle controlled study to evaluate the safety and efficacy of Cortexolone 17 alpha propionate cream 1% applied twice daily for 12 weeks with subject with Facial Acne Vulgaris.

Skip to content
Explore
Drag